Mid Europa's Walmark acquires Pneumolan

Mid Europa acquired a 50% stake in Walmark in July 2012 from the company's founders. The GP has since supported the company's buy-and-build strategy, which has seen Walmark previously acquire sinus and upper-respiratory product manufacturer Sinulan, also from Novascon, in April 2014.

Walmark was founded in 1990 and is headquartered in Třinec, Czech Republic, with an additional office in Prague. The company develops dietary supplements and exports to Slovakia, Romania, Bulgaria, Hungary, Poland and the Baltic states.

Company
Poland-based Pneumolan specialises in children's natural products for respiratory ailments. Its parent company, Novascon, was founded in 2007 and is headquartered in Warsaw.

People
Jorge Manuel is the CEO of Walmark. Michelle Capiod is a partner at Mid Europa.

Advisers
Company – Vienna Capital Partners (Corporate finance); Pharmabroker (Corporate finance); Baker & McKenzie (Legal); EY (Financial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• CEE
• Healthcare
• Mid Europa Partners
• Unq2015July